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An immobilization system constituted by coated microcapsules was developed aiming at 31 
immobilizing probiotic bacteria capable of producing folate and release it in a sustained 32 
manner into the intestine. Despite no probiotic folate-producers have been immobilized so 33 
far, the system has been developed with this goal and this work reports its stability and ability 34 
to release folate under gastro-intestinal conditions. 35 
Microcapsules were made of alginate with three consecutive coatings of poly-L-lysine, 36 
sodium alginate and chitosan. Turbidity experiments showed a strong electrostatic interaction 37 
between these polymers. Fourier transform infrared spectroscopy (FTIR) and confocal 38 
analysis showed the stability of the coating materials when applied on the microcapsules, 39 
even after they were immersed in solutions simulating conditions in the stomach and small 40 
intestine (i.e. pH 2, 60 min and pH 7.2, 120 min, respectively). Coated microcapsules have 41 
an average diameter size ranged from 20 and 40 µm, and swelled upon exposure to a neutral 42 
medium, without dissolution as showed by microscopy analyses. Release experiments proved 43 
the ability of the coated microcapsules to release folic acid, at different rates, depending on 44 
the applied coating. Release experiments showed that the first coating (Ɛ-PLL) is 45 
characterized by Fickian diffusion as the main release mechanism of folic acid. Fickian rate 46 
constant (kF) decreased with the number of consequent coatings, reflecting the decrease of 47 
predominance of Fick’s behavior. Results showed that the developed coated microcapsules 48 
have suitable characteristics for encapsulation of folic acid aiming in situ release in the 49 
intestine. 50 
 51 
1. Introduction 52 
 53 
Folate is a vitamin that occurs in a large number of forms, being all derived from folic acid 54 
(pteroylglutamic acid). However there are different forms of folate, being the most known 55 
folic acid and 5-methyltetrahydrofolic acid (Belz & Nau, 1998). Folate is part of some 56 
important metabolic pathways, such as methyl group biogenesis and synthesis of nucleotides, 57 
vitamins and amino acids (Jacob, 2000). According to the World Health Organization, folate 58 
deficiency is often associated with megaloblastic anemia, risk of low birthweight and 59 
placental abruption, risk of delivering preterm or small-for-gestational-age infants, risk of 60 
neural tube defects (NTD), depression or even dementia (de Benoist, 2008). The increased 61 
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cancer risk is also reported in other studies (Stolzenberg-solomon et al., 2006). Folate 62 
fortification in food to maintain recommended daily intake (350 µg for adults and 600 µg for 63 
pregnant women) has been used using the synthetic form of B9 vitamin, folic acid (European 64 
Food Safety Authority, 2014). However, folic acid has low bioavailability after food 65 
processing, storage and consumption, due to inefficient absorption (de Meer et al., 2005). 66 
More than that, folic acid has the capacity to mask, in an initial phase, vitamin B12 deficiency 67 
(Bailey & Ayling, 2009; Morris & Tangney, 2007), while also changing the activity of the 68 
hepatic dihydrofolate reductase enzyme (Bailey & Ayling, 2009) and promoting cancer 69 
(Baggott et al., 2012; Ulrich & Potter, 2006). Considering all these reasons, food fortification 70 
by a natural folate form is highly recommended.  71 
Some probiotic bacteria, such as Lactococcus lactis cremoris, Streptococcus thermophilus, 72 
Bifidobacterium lactis, B. breve, B. infantis and B. animalis are capable of producing large 73 
amounts of folate (Crittenden et al., 2003; Sybesma et al., 2003). However, several factors 74 
limit probiotics’ action in the human body, such as very weak resistance to gastro-intestinal 75 
conditions (Gueimonde & Salminen, 2006) and low residence time in the intestine (Gardiner 76 
et al., 2004; Klingberg & Budde, 2006). A possible solution to these problems mentioned 77 
above could be the encapsulation of folate-producers probiotics. Microcapsules are able to 78 
protect probiotics against high oxygen levels (Sunohara et al. 1995), food products (Tripathi 79 
& Giri 2014), freezing (Azizi et al. 2010; Sousa et al. 2013), and during the passage through 80 
the gastrointestinal tract (Sun & Griffiths 2000). Other limitation could be the direct contact 81 
of these bacteria with human gut, following reports mentioning concerns about the probiotics 82 
utilization in humans, such as: possible passage from the digestive tract to extra-intestinal 83 
sites, leading to infections (Butel, 2014), and an excessive immune stimulation by a direct 84 
contact of probiotics with the gut, that creates continuous immunological responses by 85 
human organism (Marteau & Shanahan, 2003). However, a full and continuous encapsulation 86 
during the passage through the gastrointestinal system can provide other advantages such as 87 
the prevention of the interfacial activation, stimulation of production and excretion of 88 
secondary metabolites (Nazzaro et al. 2012).  89 
Alginate is the most applied material in microcapsules formation due to its low price, ease of 90 
gelation and biocompatibility (Chen et al., 2012; Klein et al., 1983; Quong et al., 1998; 91 
Smidsrd & Skjak-Brae, 1990; Tanaka & Matsumura, 1983). Alginate is a polysaccharide 92 
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extracted from brown algae and is composed of randomly 1–4 linked -D-mannuronic acid 93 
and -L-guluronic acid, M blocks and G blocks, respectively (Smidsrd & Skjak-Brae, 1990). 94 
The ratio between these two blocks (M/G ratio) leads to alginates with different 95 
characteristics when crosslinked with calcium, as only G blocks bind to calcium. This has a 96 
direct influence on the encapsulation efficiency, swelling and release kinetics. In 97 
microcapsule formation, alginates with a high M/G ratio will be more permeable and will 98 
have a faster release of encapsulated compounds (Khanna et al., 2010). Alginates with a 99 
lower M/G ratio will form stronger structures, which are less permeable and more viscous 100 
due to the greater affinity of the G blocks to calcium ions, compared to M blocks (Sarmento 101 
et al., 2007). Divalent calcium (Ca2+) is the most commonly used ion to create alginate-based 102 
microcapsules, although other ions can also be used (Tam et al., 2011). There are different 103 
techniques for microencapsulation of probiotics, such as extrusion, spray drying, 104 
emulsification and coacervation (Rathore et al., 2013) but the production of microcapsules 105 
smaller than 100 µm is less common in the literature. Microcapsules smaller than 100 µm 106 
are important as they will not alter food texture (Adhikari et al., 2003) and thus their sensorial 107 
aspects. Nevertheless, depending on their hardness there are even works that refer 108 
microcapsules’ sizes of 40 µm that change food texture (Engelen et al., 2005). Sheu & 109 
Marshall (1993) produced sodium alginate microcapsules smaller than 100 µm, by emulsion 110 
technique, as support to the alginate ionotropic gelation. Considering the small diameters of 111 
microcapsules below 100 µm, and that small capsules (below 200 µm) are less efficient for 112 
probiotics protection (Heidebach et al., 2012), added barriers to protect microencapsulated 113 
probiotics have been developed, namely by using layer-by-layer (LbL) assembly. 114 
Electrostatic LbL coating involves the assembly of materials of opposite charge e.g. through 115 
exposure to alternating solutions of cationic and anionic polymers (Cook et al., 2013; 116 
Krasaekoopt et al., 2006). 117 
Different polysaccharides and proteins have been used to form LbL coatings (Tang et al., 118 
2006; Yan et al., 2014). Alginate|poly-L-lysine|alginate is a well-known combination of 119 
coatings which have been used on alginate based microcapsules. The interactions between 120 
these two polymers (alginate and poly-L-lysine (PLL)), in most cases leading to a LbL 121 
assembly, are based in the electrostatic interactions between the anionic groups COO- present 122 
in alginate and the cationic groups NH3
+
 present in PLL (Orive et al., 2006). The electrostatic 123 
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interactions of PLL are enhanced when the amount of M blocks present in alginate is higher, 124 
in others words, PLL cationic groups have more affinity for M blocks compared to the G 125 
blocks (Thu et al., 1996). Chitosan has been one of the most used materials to improve the 126 
protection of probiotics, e.g. as a coating on alginate microcapsules (Chávarri et al., 2010; 127 
Kamalian et al., 2014). Chitosan and alginate have also demonstrated mucoadhesive 128 
properties that are important to be used to increase the residence time of microcapsules in the 129 
gut (Sarmento, et al., 2007; Takeuchi et al., 2005).  130 
The objective of this work was developing an alginate-based probiotics encapsulation system 131 
smaller than 100 µm, with a rationally designed coating developed through LbL assembly. It 132 
has being developed aiming to host probiotic bacteria while being able to pass through the 133 
gastrointestinal system up to the point at which adhesion to the intestinal mucosa can be 134 
achieved, with the consequent exchange of nutrients and products (probiotic activation and 135 
a continuous encapsulation) in the intestine. This approach will increase the residence time 136 
of probiotics in the intestine and will avoid possible inflammatory responses or infections 137 
provoked by direct contact of probiotic bacteria with the intestinal mucosa. In this work will 138 
only be presented the development and characterization of the system and the results 139 
considering probiotics encapsulation and protection, as adhesion will not be explored. The 140 
developed system will be characterized in terms of size, swelling capacity, folate release 141 
behavior and the chemical interactions between the capsule and the coatings (FTIR analysis).  142 
 143 
2. Materials and methods 144 
2.1. Materials 145 
Sodium alginates “Protanal CR 8223” (M/G ratio 65/35; 250 - 350 kDa) and “Protanal 146 
LFR5/60” (M/G ratio 30/70; 20 - 60 kDa) were purchased from FMC Biopolymer (Belgium). 147 
Ɛ-poly-L-lysine (Ɛ-PLL) was purchased from Handary (Belgium – Molecular Weight - 30 148 
kDa). Chitosan was obtained from Golden-Shell Biochemical Co. Ltd. (China - molecular 149 
weight - 5-10 kDa) with a degree of deacetylation of 95 %. Corn oil, Tween 80 (Panreac, 150 
Germany), fluorescein isothiocynate (FITC), rhodamine B isothiocynate (RITC), 1-ethyl-3-151 
(-3-dimethylaminopropyl) carbodiimide hydrochloride (EDC), N,N-dimethylformamide and 152 
folic acid were purchased from Sigma (USA). 153 
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2.2. Turbidity measurements 154 
All polymer solutions (0.1 % w/v) were prepared in deionized water, except chitosan which 155 
was dissolved in a 1 % (v/v) lactic acid solution. A mixture of 5 mL of each solution was 156 
used, testing some combinations of biopolymers to be used as coating materials (sodium 157 
alginate CR 8223 with Ɛ-PLL; Ɛ-PLL with sodium alginate LFR5/60; sodium alginate 158 
LFR5/60 with chitosan). The pH of each mixture was adjusted with 0.2 mol.L-1 hydrogen 159 
chloride or 0.2 mol.L-1 sodium hydroxide solutions, in the range of 2 to 8. In order to 160 
standardize the compounds concentration in all samples after pH adjustment, sodium chloride 161 
(0.2 mol.L-1) was added to obtain the same final volume in all experiments. Turbidity 162 
measurements were performed on a spectrophotometer at 400 nm (Jasco V560, Jasco 163 
Corporation, Japan).  164 
2.3. Microcapsules production 165 
Microcapsules were produced according to the method described by Sheu & Marshall (1993). 166 
These first tests were performed without bacteria to facilitate coated microcapsules 167 
characterization. The microcapsules were produced by dropwise addition of 20 mL sodium 168 
alginate (CR 8220), with a concentration of 1.5 %, into a 100 mL solution of vegetable oil 169 
with a concentration of 0.2 % of Tween 80. The mixture was then stirred for 10 min at 170 
200 rpm. After this, a solution of 200 mL of calcium chloride (0.05 M) was gently added 171 
during 20 s and the mixture stirred at 200 rpm for 20 min. After hardening, the solution was 172 
passed to a separatory funnel, where it remained for 30 min. After this, the liquid (oil and 173 
water) was gently removed with a pipette. The residual volume containing the microcapsules 174 
was then filtered through a 100 µm nylon filter using water to remove the residual oil. After 175 
filtration the microcapsules that passed through the filter (smaller than 100 µm) were 176 
centrifuged for 5 min at 600 rpm (Centrifuge Heraeus Megafuge 1.0R) and isolated. 177 
2.4. Layer-by-layer assembly - Coated microcapsules production 178 
After production, the microcapsules were immersed in a 0.01 % Ɛ-PLL solution (10 mL), 179 
with constant stirring of 200 rpm for 15 min, forming the coated microcapsules with a single 180 
coat. Then, the solution was centrifuged in the manner mentioned before. The next step was 181 
the immersion of the coated microcapsules (alginate|Ɛ-PLL) into a sodium alginate 182 
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(LFR5/60) solution (0.1 %, 10 mL) for 15 min, followed by centrifugation (600 rpm, 10 min). 183 
The recovered coated microcapsules (double coated) were then immersed into a chitosan 184 
solution (0.01 %, 10 mL). After that, another centrifugation step separated the coated 185 
microcapsules from the chitosan solution.  186 
2.5. Fourier transform infrared (FTIR) spectroscopy  187 
In order to confirm the adhesion of the different coatings, FTIR analyses were carried out 188 
with a Perkin Elmer 16 PC spectrometer (Perkin Elmer, Boston, MA, USA) in the 189 
wavenumber region of 600 - 4000 cm-1 using 16 scans for each sample. The microcapsules 190 
and coated microcapsules were freeze-dried prior to FTIR measurements.  191 
2.6. Diameter measurement 192 
Diameter measurements were performed through microscopy with a 10 magnification 193 
(Olympus BX51). Images of the samples were taken and at least 200 capsules were measured 194 
with Image J software. 195 
2.7. Testing of microcapsules and coated microcapsules in different pH’s 196 
Microcapsules and coated microcapsules were immersed into a 10 mL solution of potassium 197 
chloride - hydrogen chloride (pH 2) for 1 h, stirred at 100 rpm. Then, the solution was 198 
centrifuged and the microcapsules and coated microcapsules were put into a phosphate buffer 199 
saline (PBS) solution (pH 7.2), for 3 h. Aliquots of 100 µL were taken every 15 min. During 200 
the PBS solution test, that have a duration of 3 h, samples were taken every 45 min. Each 201 
experiment was performed in triplicate. These experiments were performed in microcapsules 202 
and coated microcapsules with one coating (Ɛ-PLL), two coatings (previous coating and 203 
alginate) and with three coatings (previous coatings and chitosan). All these experiments 204 
were performed independently and in triplicate. For each sample, diameter measurements 205 
were performed. 206 
2.8. Compounds labeling 207 
Chitosan-[RITC] was prepared by mixing 100 mL of 1 % chitosan with 50 mg RITC and 208 
20 mg EDC at 4 ºC for 1 day. Alginate-[FITC] was prepared by mixing 100 mL of 1.76 % 209 
alginate with 10 mg FITC and 20 mg EDC at 4 ºC for 1 day. The residual free dye was then 210 
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dialyzed off (molecular weight  cut-off 3500 Da; Cell-Sep H1, Membrane Filtration products, 211 
USA) with double distilled water for 2 weeks (Chang et al., 2012). To the FITC-labeled Ɛ-212 
PLL, 0.1 % of a Ɛ-PLL solution was dissolved in 0.2 M NaHCO3 buffer (pH 9) and 1.0 mg 213 
(0.0026 mmol) of FITC was dissolved in N,N-dimethylformamide. Both solutions were 214 
stirred overnight. The Ɛ-PLL/FITC solution was purified by dialysis (molecular weight cut-215 
off 1000 Da; Cell-Sep H1, Membrane Filtration products, USA) and the compound was dried 216 
by freeze-drying for further utilization (Kleinberger et al., 2013).  217 
 218 
2.9. Confocal microscopy analyses during the gastrointestinal pH simulation 219 
The same media and conditions were used as mentioned in section 2.7 but samples were 220 
taken at 5 min and 60 min in the potassium chloride - hydrogen chloride medium and at 5 221 
min and 3 h in the PBS medium. All samples were analyzed by confocal microscopy (Nikon 222 
A1-R Confocal with Resonant Scanner). Independent experiments were performed where 223 
just the studied coating was labeled. 224 
 225 
2.10. Kinetic release profiles 226 
The release kinetics of folic acid was studied using an in vitro dialysis method. Folic acid 227 
was added to sodium alginate solution used for microcapsules’ production, forming a 228 
solution with a concentration of folic acid of 2 %. The process of coated microcapsules’ 229 
production was the same as mentioned before. Each production batch (10 mL volume) was 230 
divided in two different experiments. Each experiment had 5 mL of coated microcapsules 231 
that were introduced in a dialysis membrane (molecular weight cut-off 15 kDa, Cellu-Sep 232 
H1, Membrane filtration products, USA), which was subsequently placed into 40 mL of PBS 233 
solution, under magnetic stirring, at 37 ºC, with no exposure to light. At appropriate time 234 
intervals, 0.8 mL of supernatant were taken and fresh medium was replaced to keep the initial 235 
volume constant. The amount of folic acid released from the coated microcapsules was 236 
evaluated by measuring the absorbance at 309 nm (Elisa Biotech Synergy HT, Biotek, USA). 237 
Coated microcapsules were produced without folic acid and a release experiment was 238 
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performed proving that no significant absorbance could be measured from the samples of 239 
that experiment.  240 
All the tests were run at least in triplicate. 241 
 242 
Mathematical Modeling 243 
Folic acid release profile from the coated microcapsules was evaluated using a kinetic model 244 
that accounts for both Fickian and Case II transport (linear superposition model - LSM) 245 
effects in hydrophilic matrices (Berens & Hopfenberg, 1978b): 246 
Mt = MF + MR          (Eq.1) 247 
where Mt is the total mass released from the coated microcapsule, MF and MR  are the 248 
contributions of the Fickian and relaxation processes, respectively, at time t.  249 
The Fickian process is described by:  250 
𝑀𝑡, 𝐹 = 𝑀∞, 𝐹 [1 −
6
𝜋2
∑
1
𝑛2
∞
𝑛=1 exp⁡(−𝑛
2𝑘𝐹𝑡)]       (Eq.2) 251 
where                                                 252 
 𝐾𝐹 =
4𝜋2𝐷
𝑑2
          (Eq. 3) 253 
M∞,F is the compound release at equilibrium, D is diffusion coefficient and d is the capsule 254 
diameter. 255 
As for polymer relaxation, it is driven by the swelling ability of the polymer and it is therefore 256 
related to the dissipation of stress induced by the entry of the penetrant and can be described 257 
as a distribution of relaxation times, each assuming a first order-type kinetic equation (Berens 258 
& Hopfenberg, 1978a). 259 
 260 
𝑀𝑡, 𝑅 = ∑ 𝑀∞, 𝑖𝑖 [1 − exp⁡(−𝐾𝑖, 𝑡)]        (Eq. 4) 261 
 262 
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where each Ki is the respective relaxation rate constant and each M∞,i represents the 263 
equilibrium sorption of the ith relaxation process. 264 
 265 
Substitution of equations (Eq. 2) and (Eq. 4) into equation (Eq. 1) results in: 266 
𝑀𝑡, 𝐹 = 𝑀∞, 𝐹 [1 −
6
𝜋2
∑
1
𝑛2
∞
𝑛=1 exp⁡(−𝑛
2𝑘𝐹𝑡)] + ∑ 𝑀∞, 𝑅𝑖𝑖 [1 − exp⁡(−𝐾𝑅𝑖, 𝑡)] (Eq.5) 267 
This “general” model can then be used to describe pure Fickian (Mt,F ≠ 0 and i = 0); 268 
anomalous (Mt,F and i ≠ 0) or Case II (Mt,F = 0 and i ≠ 0) transports. 269 
 270 
2.11. Statistical analyses 271 
Statistical analyses were performed using the analyses of variance (ANOVA) procedure with 272 
SigmaPlot 11.0 software for windows, where a p<0.05 was considered to be statistically 273 
significant, on the diameter and turbidity measurements.  274 
Equation 5 was fitted to data by non-linear regression, using STATISTICA v7.0 (Statsoft. 275 
Inc, USA). The Levenberg-Marquardt algorithm for the least squares function minimization 276 
was applied. Adjusted determination coefficient (R2), squared root mean square error 277 
(RMSE) (i.e., the square root of the sum of the squared residues (SSE) divided by the 278 
regression degrees of freedom) and residuals inspection for randomness and normality were 279 
evaluated to determine regressions quality. Standardized Halved Width (SHW %) (i.e. the 280 
ratio between 95 % Standard Error and the value of the estimate) was assessed to determine 281 
precision of the estimated parameters. 282 
 283 
 284 
3. Results and Discussion 285 
 286 
The design of this system was made with the following criteria: the utilization of alginate CR 287 
8223, that has a 65/35 ratio of the M/G blocks and a high molecular weight (app. 300 kDa) 288 
was meant to form a main core with high permeability due to its high molecular weight and 289 
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high content of mannuronic residues (responsible for swelling and less affinity by calcium 290 
ions). The use of PLL, as the first coating, is expected to limit the continuous swelling of the 291 
alginate microcapsule that leads to erosion in the media containing monovalent ions and 292 
calcium sequestrants, while maintaining the permeability of the coated microcapsule. The 293 
subsequent coating, alginate LFR5/60, has a 30/60 M/G ratio and a low molecular weight. 294 
PLL has more affinity for M blocks than G blocks, which will promote electrostatic 295 
interactions between the first and the second coating (Thu et al., 1996). This second alginate 296 
coating will also work as a way to guarantee the interaction between PLL and chitosan (to be 297 
used in the third and last coating), maintaining the permeability of the system, and working 298 
as a bioadhesive material in the case of chitosan erosion. Chitosan used as the last coating 299 
has two main objectives: to protect the system (mainly the probiotics) in acidic environments 300 
and be responsible for the adhesion of coated microcapsules to the intestinal epithelium. The 301 
presented system, with the utilization of these specific materials and with that specific order, 302 
was never used before for the development of a coated microcapsule system. The 303 
combination of these materials create a new coated microcapsule system that might have new 304 
functions and applications, such as the controlled release of micronutrients. Some of these 305 
characteristics will be studied and demonstrated in this work, others will be explored in a 306 
future work.  307 
 308 
3.1. Turbidity measurements 309 
Turbidity tests were performed to demonstrate that the coating materials effectively interact 310 
with each other via their charged groups, which are responsible by the electrostatic 311 
interactions established between them. The materials used to build the different coatings on 312 
the alginate microcapsules were: a) alginate CR 8223, negatively charged material at pH 313 
values above its pKa; b) Ɛ-PLL, positively charged material at pH values below its isoelectric 314 
point (pI); c) alginate LFR5/60, negatively charged material at pH values above its pKa (An 315 
et al., 2013; Cook et al., 2012); d) chitosan, positively charged material at pH values above 316 
its pKa. 317 
The turbidity of these four different solutions was measured at pH values between 2 and 8, 318 
ensuring that the OD was never above 0.08 a.u. This confirms that any turbidity above this 319 
is the result of polyelectrolyte complex formation. The first experiment was performed with 320 
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alginate CR 8223 and Ɛ-PLL. The results showed a better interaction between the 321 
biopolymers at pH 5 - 6 (Figure 1), as shown by higher OD values, being those statistically 322 
different for all experiments but not different at pH 4 (p<0.05). The rest of the experiments 323 
are all statistically similar, but their minimal values of OD (0.68 ± 0.05) are considerably 324 
higher than the OD of the pure solutions, which indicates that electrostatic interactions 325 
occurred between these materials in all the pH range tested. These results can be justified 326 
considering that the pKa of alginate is 3.3 - 3.7 (pKa values of mannuronic acid and guluronic 327 
acid are 3.38 and 3.65, respectively (An et al., 2013)) and that the pI of Ɛ-PLL is of 328 
approximately 9 (Yoshida & Nagasawa, 2003). The interactions observable at pH 2 and 3 are 329 
possibly due to a remaining percentage of functional groups charged in alginate at these pH 330 
values (pH at one unity below the pKa of alginate, the molecule will still have 10% of the 331 
functional groups charged (Po & Senozan, 2001)).  332 
 333 
Figure 1 – Turbidity measurements for Alginate CR 8223, Ɛ-PLL, Alginate LFR5/60 and 334 
Chitosan. Different letters represent significantly different values (p<0.05). 335 
 336 
The same experiment was performed with Ɛ-PLL and alginate LFR5/60 solutions (Figure 1), 337 
which correspond to the first and second coating of the microcapsule, respectively. The 338 
results showed that the strongest interactions between the two materials happen between pH 339 
3 and 8, where no statistically significant differences are observed in that interval (p<0.05). 340 
As mentioned before, the lower OD obtained at pH 2 can be justified by a lower number of 341 
negatively charged functional groups in alginate, at this pH. These results have a similar 342 
behavior when compared with the interactions between alginate CR8223 and Ɛ-PLL and 343 
similar electrostatic interactions are present in this experiment. It is also important to mention 344 
that the observed OD values are higher, in general, when comparing the interaction of 345 
alginate LFR5/60 and alginate CR 8223 with Ɛ-PLL. This fact can be justified by the 346 
strongest affinity of the amine groups of Ɛ-PLL with the glucuronic residues (present in 347 
alginate) that are in a higher percentage in the alginate LFR5/60 (Thu et al., 1996). 348 
The turbidity measurements performed with alginate LFR5/60 and chitosan showed that pH, 349 
as before, influenced the results (Figure 1). The pKa values of alginate and chitosan are 3.3 350 
– 3.7 and 6.5 (Oliveira et al., 2014), respectively, which indicates that strong interactions are 351 
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to be expected between the biopolymers at pH values between 3 and 5, being those 352 
statistically different of the rest (p<0.05) (as mentioned above, at pH values near the pKa, 353 
half of the molecule’s functional groups are charged). The results obtained between pH 6 and 354 
8 cannot be differentiated from a statistical point of view, which considering that those values 355 
are at the chitosan pKa or above that, means that chitosan is reducing the number of its 356 
functional groups with positive charge, and is starting to precipitate. In the tests at lower pH 357 
(pH 2) the same is happening but with the alginate molecule. Electrostatic forces are present 358 
in the interaction of chitosan with alginate thus creating this significant turbidity (Chávarri 359 
et al., 2010). The interaction of these materials were also demonstrated in other works where 360 
a capsule constituted by alginate and PLL was produced (Constantinidis et al., 2007; Tam et 361 
al., 2005b). In other works were also proved the interaction of alginate and chitosan on the 362 
production and coating of a microcapsule (Shi et al., 2007a; Zhao et al., 2007). 363 
Turbidity results show that the materials used are able to interact, being a good indication of 364 
the formation of a LbL structure on the microcapsule. This evaluation is also important to 365 
demonstrate that the developed system is stable for pH values between 2 and 7 (i.e. stomach 366 
and intestine), which gives good perspectives to the utilization of this coated microcapsule 367 
as a gastrointestinal delivery system. After turbidity tests the concentrations of the solutions 368 
were optimized by ζ- potential measurements in order to add successfully the different 369 
coatings to the microcapsule. These tests were conducted as described in Carneiro-da-Cunha 370 
et al. (2010) and the best solutions achieved were 0.01 % for Ɛ-PLL, 0.1 % for alginate and 371 
0.01 % for chitosan. 372 
 373 
3.2. Size measurement  374 
 375 
Figure 2 shows the diameter of the coated microcapsules through consecutive coating steps, 376 
demonstrating that coated microcapsules produced using this method are smaller than 100 377 
µm, achieving that way the first goal of this work (microcapsules/coated microcapsules to 378 
protect bacteria that do not alter the texture/mouthfeel of the food product they are to be 379 
dispersed in). During sequential coating steps, the coated microcapsules’ diameter decreased, 380 
comparing with microcapsules, phenomena that can be explained by the different behavior 381 
of these materials at different pH values. The alginate used in the microcapsules production 382 
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has the capacity to swell through hydration that increased the microcapsules volume; this 383 
happens after the production in the final washing step with water. This was also reported by 384 
Sriamornsak et al. (2007) that tested a great number of alginates types and proved that 385 
alginate-based matrices are susceptible to hydrate at a neutral pH. After generating the main 386 
core, the microcapsules were added to a solution of Ɛ-PLL, creating the alginate|Ɛ-PLL 387 
coated microcapsule (APM). This deposition decreased the diameter of the coated 388 
microcapsules in comparison with the alginate microcapsules, in a neutral pH, due to the first 389 
coating formation. When APM were put into water the swelling was reduced by the Ɛ-PLL 390 
layer. This behaviour can be explained by the capacity of this coating to limit the high 391 
hydration capacity, and consequent swelling capacity, of alginate microcapsules (Lawrie et 392 
al., 2007). The consequent layers adhesion creating the alginate|Ɛ-PLL|alginate coated 393 
microcapsule (APAM) and alginate|Ɛ-PLL|alginate|chitosan (APACM) did not change the 394 
diameter of the coated microcapsules, being the diameter results for the three coated 395 
microcapsules statistically equal and all different from the microcapsule diameter (p<0.05).  396 
 397 
 398 
Figure 2 – Microcapsule and coated microcapsules diameter through the coatings deposition 399 
(capsules are immerged in water), A; and coated microcapsules’ picture by microscope with 400 
a 10x lent (scale bar 150 µm), B. Different letters represent significantly different values 401 
(p<0.05). 402 
 403 
3.3. FTIR results 404 
FTIR results showed a significant similarity between the microcapsules spectra main peaks 405 
and those of alginate CR 8223 (Figure 3), in both, the characteristic peaks of alginate at 3309 406 
cm-1 (stretching vibrations of hydrogen-bonded OH groups), 1590 cm-1 and 1400 cm-1 407 
(stretching vibrations of the COO- - Figure 3 (B)) are present (Shi et al., 2007; Tam et al., 408 
2005). Just on microcapsules spectrum, two consequent peaks can be found at 2922 and 2852 409 
cm-1 (Figure 3 (A)) and another one at 1743 cm-1 (Figure 3 (C)), both being the consequence 410 
of the presence of oil (Meng et al., 2014; Vlachos et al., 2006). 411 
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 412 
Figure 3 - FTIR spectra of alginate powder and alginate microcapsules. A – representation 413 
of 2852 and 2922 cm-1 peaks; B – representation of 1590 and 1400 cm-1 peaks; C – 414 
representation of the 1743 cm-1 peak. 415 
 416 
Considering the spectra presented in Figure 4, it is possible to identify that the oil spectra 417 
keep being present in all samples. The consequent coating adhesion showed that there are no 418 
significant modifications between the alginate microcapsules spectra and the coated 419 
microcapsules spectra. On the alginate microcapsules and APM spectra there are relevant 420 
differences such as the formation of two shoulders on both sides of peak 1590 (Figure 4 (A)), 421 
that correspond to the strong Amide I (~1637 cm-1) and Amide II (~1552 cm-1) OD bands of 422 
the Ɛ-PLL (Tam et al., 2005). The presence of those peaks proves the presence of Ɛ-PLL in 423 
the APM structure. The presence of alginate LFR5/60 is difficult to prove considering that 424 
its spectra is the same as the one of the initial alginate microcapsule, although it is possible 425 
to notice that the two shoulders presented in the last spectrum (APM spectra) characteristic 426 
of Ɛ-PLL, disappear in the APAM spectrum which proves that the alginate coating was well 427 
succeed. Some characteristic peaks can be seen in Figure 4 (B) in the APACM spectrum, that 428 
are characteristic of the presence of chitosan, such as the one found at 1567 cm-1; this is a 429 
typical peak of the interaction between the negatively charged group COO- of alginate and 430 
the positively charged groups NH3
+ of chitosan. This peak is also responsible for the 431 
obstruction of the 1590 cm-1 alginate peak. This behavior can be found in other works dealing 432 
with the coating of alginate with chitosan (Shi et al., 2007b). The 1729 cm-1 peak (Figure 4 433 
(C)) can be justified by the protonation of alginate, due to the contact of chitosan (dissolved 434 
in lactic acid) with alginate (Lawrie et al., 2007). These FTIR results show the successive 435 
adhesion of the different coatings.  436 
 437 
Figure 4 - FTIR spectra of alginate microcapsule, APM, APAM and APACM. 438 
 439 
3.4. Confocal microscopy analyses 440 
The LbL assembly on alginate microcapsules was evaluated through confocal microscopy in 441 
order to show the adhesion of the materials to the main core microcapsule structure (Figure 442 
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5). Alginate CR 8223, Ɛ-PLL and alginate LFR5/60 were labeled with FITC and chitosan 443 
was labeled with rhodamine. To test the presence of each coating only one coating was 444 
labeled in each experiment, in order to differentiate all the coatings that were labeled with 445 
FITC. Confocal microscopy images showed the existence of the alginate-based 446 
microcapsules (Figure 5a). Figure 5b) shows the coated microcapsules labeled with Ɛ-PLL, 447 
coated due to the electrostatic forces between CO2
- groups, from alginate, and NH3
+ from Ɛ-448 
PLL (Bystrick et al., 1990). Figure 5c) shows the adhesion of the second coating, composed 449 
of alginate LFR5/60. Figure 5d) shows the presence of the subsequent chitosan layer on that 450 
of alginate LFR5/60 coated microcapsule, being its adhesion justified by electrostatic forces 451 
between the carboxyl groups of alginate and the amine groups of chitosan (NH2
+) (Gazori et 452 
al., 2009; Sarmento et al., 2007). With these confocal images it was possible to prove the 453 
sequential adhesion of those different coatings to the main microcapsule structure.  454 
 455 
Figure 5 – Representation of: a) alginate coated microcapsules (alginate labeled with FITC - 456 
scale 250 µm); b) APM (Ɛ-PLL labeled with FITC - scale 200 µm); c) APAM (alginate 457 
labeled with FITC - scale 50 µm); d) APACM (Chitosan labeled with Rhodamine - scale 50 458 
µm). 459 
 460 
3.5. Evaluation of structures into two different media that simulate gastrointestinal pH 461 
Tests were performed to determine the coated microcapsules’ diameter in an acidic medium 462 
(potassium chloride - hydrogen chloride at pH 2, 1 h), simulating stomach pH, and in a neutral 463 
pH medium (Phosphate Buffer Solution (PBS) – pH 7.2 – 3 h), simulating intestinal pH. 464 
Alginate microcapsules showed a good resistance to the potassium chloride - hydrogen 465 
chloride solution, as shown in Figure 6. The structures presented an average diameter of 466 
33.81 ± 3.05 µm in that solution. 467 
 468 
Figure 6 - Microscopy images of the microcapsules after 1 h into the acidic medium (scale - 469 
150 µm). 470 
17 
 
In PBS the microcapsules had a different behavior. After 5 min they were starting to dissolve, 471 
making the measurement of their size impossible. This is due to exchange between the 472 
sodium ions present in the PBS solution and the calcium ions present in the alginate 473 
microcapsule, together with calcium sequestration by phosphates (Corona-Hernandez et al., 474 
2013). This process generates an increase of repulsion between the COO- groups present in 475 
the alginate chains leading to a swelling of the structure (water intake), at an initial stage, 476 
which will later lead to a total collapse of the alginate microcapsule structure. Bajpai et al. 477 
(Bajpai & Sharma, 2004) showed that alginate beads had the same behavior into a PBS 478 
solution, increasing their diameter during the first 3 h and leading to a total dissolution of the 479 
materials after that. Similar results were reported by Gao et al. (2009). 480 
To avoid the coated microcapsules’ dissolution in the PBS medium, a coating was added on 481 
the alginate microcapsule. This coating will presumably lead to an increase of the structure’s 482 
strength decreasing its swelling and thus avoiding dissolution. Some authors have shown that 483 
the utilization of Ɛ-PLL as a coating on alginate microcapsules decreased the swelling degree 484 
of the alginate microstructure in a monovalent ions solution such as PBS (Capone et al., 485 
2013; Tam et al., 2011). Figure 7 shows the diameter of the coated microcapsules when 486 
immerged in potassium chloride - hydrogen chloride and PBS solutions. It is clear that a) 487 
there is no destruction of the coated microcapsules in the PBS solution; b) coated 488 
microcapsules’ diameter is stable during the contact with the different media and there are 489 
no statistically significant differences between all diameters results in the potassium chloride 490 
- hydrogen chloride solution for all systems (p < 0.05) (average diameter of app. 20 µm ) and 491 
the same happens in the PBS solution, also for all systems (p < 0.05), being the average 492 
diameter around 40 µm; and c) there is a swelling degree of approximately 2-fold in diameter 493 
when coated microcapsules go from the potassium chloride - hydrogen chloride solution to 494 
the PBS solution, being that difference statistically significant. The Ɛ-PLL coating showed 495 
that it was able to protect the structure against the ion exchange process, thus retarding its 496 
swelling. 497 
 498 
 499 
18 
 
Figure 7 – Microcapsules and coated microcapsules diameter during immersion in potassium 500 
chloride - hydrogen chloride (0 to 60 min) and PBS (60 to 240 min) solutions in a consecutive 501 
way, respectively. Different letters represent significantly different values (p < 0.05). 502 
 503 
  504 
Confocal microscopy was performed in order to evaluate the eventual loss of layers during 505 
the contact with the potassium chloride - hydrogen chloride and PBS media. As explained 506 
before, to test the presence of each coating only one coating was labeled in each experiment, 507 
in order to differentiate all the coatings that were labeled with FITC. Figure 8 shows that the 508 
three different coatings were still over each other and attached to the main structure. Those 509 
results are in accordance with other published works (Cui et al., 2000; Kamalian et al., 2014; 510 
Krasaekoopt et al., 2006; Tam et al., 2011). 511 
 512 
 513 
Figure 8 – Microcapsules and coated microcapsules after 3 h into the PBS medium (with a 514 
previous contact of 1 h into potassium chloride - hydrogen chloride medium): a) alginate-515 
based microcapsule (alginate labeled with FITC - scale 100 µm); b) APM (Ɛ-PLL labeled 516 
with FITC - scale 25 µm); c) APAM (alginate labeled with FITC - scale 100 µm); d) APACM 517 
(chitosan labeled with rhodamine - scale 100 µm). Independent experiments were performed 518 
where only the studied coating was labeled. 519 
 520 
 521 
3.6. Release kinetics of folic acid into phosphate buffer 522 
Mathematical modelling of transport phenomena is important for the design of carrier 523 
systems and of active compound carriers, since it may help predicting behavior in vivo. In 524 
this work, we studied the description of experimentally obtained data by the Linear 525 
Superimposition Model (LSM) (Eq. 5). The mechanisms of folic acid release from coated 526 
microcapsules were evaluated at 37 °C (temperature within the human body) and at pH 7 (pH 527 
of the small intestine). 528 
In order to evaluate the physical mechanisms involved in folic acid release from coated 529 
microcapsules with different coatings it is important to use a model that successfully 530 
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describes the individual contributions of the diffusion and the relaxation processes. The LSM 531 
was fitted to the experimental data: concerning the Fickian part of the model (MF, Eq. 2) and 532 
the relaxation part of the model (MR, Eq. 4). As reported by other works, this model assumes 533 
that the transport mechanism from coated microcapsules: i) can be due only to the 534 
concentration gradient and polymer relaxation had no effect on the transport mechanism (i.e. 535 
Fick’s behavior; i = 0); or ii) transport can be due to the sum of concentration gradient and 536 
to the relaxation of the polymer matrix (i ≠ 1) (Pinheiro et al., 2013). 537 
Figure 9 clearly shows the effect of applying different coatings on coated microcapsules in 538 
the folic acid release profile. For each coating applied on the coated microcapsule, LSM 539 
fitting curves showed a good description of the experimental data. This indicates that this 540 
transport mechanism cannot be described by Fick´s diffusion of folic acid in the coated 541 
microcapsules alone, but is governed by both Fickian and Case II transport. Also, it was 542 
observed that depending on the coating applied in the coated microcapsules, this system was 543 
governed by two or more relaxation processes. 544 
 545 
 546 
 547 
Figure 9 – Profile of folic acid release from coated microcapsules at 37 °C in PBS; 548 
experimental data (×) and description of LSM (-) for coated microcapsules with A) first 549 
coating Ɛ-PLL, B) second coating alginate and C) third coating chitosan.  550 
 551 
Table 1 presents the regression analysis results of the LSM fitting, showing that this model 552 
adequately describes the experimental data with relatively good regression quality (R2 > 0.90) 553 
and that most parameters were estimated with good precision. 554 
 555 
Table 1. Results of LSM fitting to experimental data of folic acid release from coated microcapsules. 556 
Quality of the regression based on RMSE and R2 evaluation. Estimates’ precision is evaluated using 557 
the SHW% (in parenthesis). 558 
 559 
 560 
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The fitting of LSM model to experimental data shows that the mechanisms involved in folic 561 
acid release are composed by Fick diffusion contribution (MF) and two or more relaxation 562 
processes (MR). The application of the first coating (Ɛ-PLL) on the coated microcapsule 563 
suggests that Fick’s diffusion is the main mechanism of folic acid release from the coated 564 
microcapsule. These results can be explained based on strong electrostatic interactions 565 
between alginate CR 8223 and Ɛ-PLL at pH 7 (pH of PBS). As mentioned above (section 566 
3.1), at this pH the interaction between these materials is mainly due to the high affinity of 567 
the charges between the molecules (alginate – negative charge; Ɛ-PLL – positive charge). 568 
Increasing the number of coatings on the coated microcapsule leads to a decrease of the Fick 569 
diffusion contribution and to the appearance of three relaxation steps. In fact, Figure 10 570 
shows that the anomalous transport considering two main relaxations (i=2) was unable to 571 
predict the experimentally observed behavior and, hence, the physical mechanism of the 572 
transport phenomena involved for the coated microcapsule with the second and third coating 573 
was changed. This reflects that with these two last coatings the structure is more unstable, 574 
which means that the electrostatic interactions between alginate CR 8223|Ɛ-PLL|alginate 575 
LFR5/60 and alginate CR 8223|Ɛ-PLL|alginate LFR5/60|chitosan are weaker. This leads to 576 
the loosening of coated microcapsule’ structure and promotes the release of folic acid due to 577 
polymer relaxation at different times. Also the relaxation rate constant (kR) decreased with 578 
the number of coatings, supporting this hypothesis. The rate at which folic acid molecules 579 
pass though the coated microcapsule layers decreases with the increase of the number of 580 
layers in the structure. Fickian rate constant (kF) also decreased with the number of coatings, 581 
reflecting the decrease of predominance of Fickian behavior.  582 
 583 
Figure 10 – Fitting of Eq. 5 to the experimental data of controlled release of folic acid from 584 
coated microcapsules with: A) second coating and B) third coating (experimental results (x) 585 
and model-generated values for i=2 (-) and i=3 (-)). Inset shows the detail of the model fitting 586 
to the initial experimental data. 587 
 588 
The diffusion coefficient (D) was estimated based on Eq. 4 and it is possible to observe that 589 
this parameter was influenced by the composition of the coatings on the coated microcapsule. 590 
The application of a second coating decreases D from 3.73x10-13 to 1.256x10-13 m2.min-1 and 591 
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this last value remained constant for the third coating. These results suggest that the 592 
application of the second coating led to a slow, limiting step of the release of folic acid. This 593 
fact can also be explained by the utilization of two different alginates: the alginate used for 594 
the microcapsule production is more permeable, with a higher swelling capacity, while the 595 
one used as the second coating is more stable, with more G residues (more connection points 596 
leading to a stronger adhesion to the adjacent layers), being these characteristics the main 597 
differences of these two alginates (Draget & Taylor, 2011). Similar results in the release of 598 
folic acid from alginate-based capsules can be found in other works (Madziva et al., 2005; 599 
Pérez-Masiá et al., 2015) 600 
 601 
 602 
4. Conclusions 603 
This work showed that it is possible to build coated microcapsules with three coatings (Ɛ-604 
PLL, alginate and chitosan) with a good stability at different pH values. This allowed us to 605 
foresee that this coated microcapsule may have a good performance in probiotic protection 606 
under GIT conditions. The coated microcapsule has an average diameter smaller than 607 
100 µm, thus being not detected in the mouth. Results also showed that its porosity will 608 
increase at neutral pH, allowing an increased exchange of nutrients and products e.g. between 609 
encapsulated cells and the intestinal medium, although further tests need to be done to show 610 
this. According to the folic acid release experiments it was proved that this coated 611 
microcapsule is permeable to folic acid, even when three coatings are applied on it, although 612 
it was also shown that the increase of the number of coatings decreases the folic acid 613 
diffusivity through capsules. 614 
 615 
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